Thermo Fisher Scentific

Context: TMO has been on a strong run, gaining about 34% since April and recently reaching around US$629. The steady climb reflects confidence in its healthcare and life sciences businesses.

$Thermo Fisher Scentific(TMO.US)

My trade: I bought TMO around the April lows and have held through the recovery. I have not taken profits yet, as I consider TMO a stronger-moat stock that I’m more comfortable holding for longer.

Takeaway: TMO benefits from its scale, broad product range and strong position in life sciences. Will continue holding while watching valuation and any slowdown in research and healthcare spending.

I like Thermo Fisher Scientific because it serves as a backbone of the life sciences industry, supplying the tools, equipment, and services that researchers, hospitals, and pharmaceutical companies rely on day in day out. While biotech spending can fluctuate, its diversified business model, recurring revenue, and broad customer base provide resilience. I believe Thermo Fisher is well positioned to benefit from long-term growth in healthcare innovation and scientific research.

$Thermo Fisher Scentific(TMO.US) Down on Revenue Miss

Source: TrendSpider

$Thermo Fisher Scentific(TMO.US) | Thermo Fisher Scientific Inc, Q1-2026 Earning Report

Source: Hardik Shah